Bioanalysis. 2010 Feb;2(2):237-47.

Systematic analytical validation of commercial kits for the determination of novel biomarkers for clinical drug development.

Source

CEDRA Corporation, 8609 Cross Park Drive, Austin, TX 78660, USA. wnowatzke@cedracorp.com

Abstract

The use of biomarkers during clinical drug-development programs may expedite pipeline decision making by adding critical information about the pharmacological mechanism and efficacy of a potential therapeutic agent. Currently, advice for laboratorians conducting method development and analytical validation of biomarker methods is provided by published White Paper recommendations from industry thought leaders. The adaptation of commercial test kits to generate biomarker data to support regulated studies offers unique challenges and limitations. In this perspective, we address these issues, including factors to consider when identifying a kit manufacturer and adapting commercial test kits for use in regulated studies. We offer a logical and systematic approach for defining the extent of analytical validation needed for application of commercial kits based upon the intended use of the biomarker data.

PMID:: 21083307; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

Biological Markers

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Supplemental Content

Save items

Related citations in PubMed

Review Insights in the application of research-grade diagnostic kits for biomarker assessments in support of clinical drug development: bioanalysis of circulating concentrations of soluble receptor activator of nuclear factor kappaB ligand. [J Pharm Biomed Anal. 2008]
Review Insights in the application of research-grade diagnostic kits for biomarker assessments in support of clinical drug development: bioanalysis of circulating concentrations of soluble receptor activator of nuclear factor kappaB ligand.
Bowsher RR, Sailstad JM. J Pharm Biomed Anal. 2008 Dec 15; 48(5):1282-9. Epub 2008 Sep 27.
Review Method validation of protein biomarkers in support of drug development or clinical diagnosis/prognosis. [J Chromatogr B Analyt Technol ...]
Review Method validation of protein biomarkers in support of drug development or clinical diagnosis/prognosis.
Lee JW, Hall M. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 May 1; 877(13):1259-71. Epub 2008 Nov 18.
Review The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity. [Toxicol Appl Pharmacol. 2010]
Review The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
Amacher DE. Toxicol Appl Pharmacol. 2010 May 15; 245(1):134-42. Epub 2010 Feb 26.
Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support pre-clinical and clinical studies. [J Pharm Biomed Anal. 2011]
Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support pre-clinical and clinical studies.
Valentin MA, Ma S, Zhao A, Legay F, Avrameas A. J Pharm Biomed Anal. 2011 Jul 15; 55(5):869-77. Epub 2011 Mar 29.
Review Method validation and application of protein biomarkers: basic similarities and differences from biotherapeutics. [Bioanalysis. 2009]
Review Method validation and application of protein biomarkers: basic similarities and differences from biotherapeutics.
Lee JW. Bioanalysis. 2009 Nov; 1(8):1461-74.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Systematic analytical validation of commercial kits for the determination of nov...
Systematic analytical validation of commercial kits for the determination of novel biomarkers for clinical drug development.
Bioanalysis. 2010 Feb ;2(2):237-47.

PubMed
Characterization of four novel ras-like genes expressed in a human teratocarcino...
Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line.
Mol Cell Biol. 1990 Apr ;10(4):1793-8.

PubMed
Torcetrapib for animal and human pharmacokinetic studies: applicability of chira...
Torcetrapib for animal and human pharmacokinetic studies: applicability of chiral and achiral methodologies.
Bioanalysis. 2009 Jun ;1(3):619-28.

PubMed
Inference of haplotypes from PCR-amplified samples of diploid populations.
Inference of haplotypes from PCR-amplified samples of diploid populations.
Mol Biol Evol. 1990 Mar ;7(2):111-22.

PubMed
Notch signaling: from stem cell expansion to improving cord blood transplantatio...
Notch signaling: from stem cell expansion to improving cord blood transplantation.
Expert Rev Hematol. 2010 Aug ;3(4):401-4.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: